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Magnetic drug targeting has emerged as a promising approach for enhancing the efficiency of drug delivery. 
Recent developments in real-time monitoring techniques have enabled the guidance of magnetic nanoparticles 
(MNPs) in the vascular network. Despite recent developments in magnetic navigation, no comprehensive strategy 
for swarm of nanoparticles steering under fluid flow exists. This paper introduces a strategy for MNPs steering in 
a vascular network under fluid flow. In the proposed scheme, the swarm of nanoparticles are initially guided to 
an area that guarantees their successful guidance towards a desired direction (called safe zone) using an 
asymmetrical field function to handle swarm of nanoparticles. Then, a transporter field function is used to transfer 
the particles between the safe zones, and finally a sustainer field function is used to keep the particles within the 
safe zone. A steering algorithm is proposed to enhance the targeting performance in the multi-bifurcation vessel. 
Utilizing the proposed concept, a high success rate for targeting is achieved in simulations, which demonstrates 
the potential and limitations of swarm of nanoparticles steering under fluid flow. 
Keywords: 
Swarm, Magnetic nanoparticles, Electromagnetic actuation, Blood vessels, Targeted Drug Delivery 
1 Introduction 
In recent years many small-scale devices have emerged for mechanical interventions and biological studies 
[1-3]. Magnetic manipulation systems have been developed as an efficient, minimally invasive approach for 
medical interventions [4]. Targeted drug delivery (TDD) has emerged as one of the high potential applications of 
magnetic manipulation. The primary goal of TDD is to deliver drugs to the target position. Magnetic actuation-
based systems have been developed to elevate the drug uptake. The principle of magnetic drug targeting (MDT) 
[5] is to attach the drug to the magnetic nanoparticles (MNPs) and use an external magnetic field to guide the 
therapeutic agent to the desired location [6, 7].  
Multi-coil magnetic systems have been introduced as a solution for precise magnetic steering [8-10]. More 
recently, the swarm of particle based microrobots are steered under static flow conditions [11, 12]. Despite 
interesting results, the lack of real-time in-vivo monitoring and studies under static flow pose limitations to their 
medical applications. 
Magnetic resonance imaging (MRI)-based navigation systems have been developed for particle steering and 
monitoring [13, 14]. More recently, magnetic particle imaging (MPI) based navigation systems with fast 
monitoring (t<=0.5s) and actuation were developed [15]. Considering the development of navigation systems, the 
strategies for MNPs steering under fluid flow are studied. 
Functionalized field using electromagnetic actuator (EMA) was used to steer MNPs, prevent the MNPs from 
sticking and aggregating inside the vessels [16-18]. To further study the performance of drug uptake, in-vivo 
studies under functionalized magnetic field were performed in mice and their brain tissues were examined. In the 
absence of a magnetic force, no nanoparticles were found inside the brain. With the functionalized magnetic field, 
the rates of blood brain barrier (BBB) crossing and drug uptake were improved significantly [19]. Aggregation 
increases the force exerted on the MNPs and elevates the performance of steering of MNPs in the fluid 
environment. However, in real medical applications aggregation hinders the successful delivery of nanoparticles 
especially when pathing through anatomical barriers (e.g. BBB) is involved [20]. Moreover, gravity plays a major 
role in microbids (200 µm) steering [21, 22], but for much smaller sized 0.75 to 1 µm magnetic particles, the 
aggregation size was controlled by introducing discontinuity in the magnetic field. Thus, reducing the severity of 
the gravitational effects [20]. 
In realistic scenarios, as introduced in [23], modulated flow control (MFC) and successive targeted 
embolization (STE) methods can be applied to reduce and control the blood flow, which makes the proposed 
scheme applicable. More recent works also cover in vitro and in vivo studies using MRI based navigation systems 
[21, 22]. Despite the recent developments, no electromagnetic steering strategy for swarm of nanoparticles under 
fluid flow have been studied. This paper introduces an electromagnetic actuation scheme for swarm of 
nanoparticle steering in multi-bifurcation blood vessels under magnetic force in fluid flow condition. 
In the electromagnetic steering scheme, the swarms of MNPs move in the same direction as the blood flow 
and EMAs are used to adjust their positions. The proposed scheme considers a realistic vessel and converts it into 
a multi-bifurcation channel with one input and four outputs, which resembles a blood vessel (Fig. 1).  It is assumed 
that the designed EMA can keep the rod-shaped aggregated MNPs inside a safe zone [17] (the space between the 
vessel boundary and the middle vessel line, as shown in Fig. 2 B) and guide them towards the desired outlet. The 
steering function (SF), which consists of three parts (shown in Fig. 2 C), is designed to guide the particles toward 
the desired outlet in the multi-bifurcation network. The main concept of multi-bifurcation steering is guiding the 
particles inside the safe zones and transferring the particles between the safe zones when the MNPs reach a 
bifurcation. Fig. 2 B illustrates the multi-bifurcation guidance strategy for a sample network. 
This paper is organized as follows: section 2 presents the proposed model and algorithm; section 3 gives the 
simulation results and discusses them; and section 4 presents the conclusions. 
 
2 Method 
2 1 Modeling for particle steering 
The size of nanoparticles can vary depending on the clinical application (the biological barrier that they were 
designed to cross). It also depends on the magnetic field applied. Further information regarding clinical use of 
MNPs and method for steering smaller MNPs can be found in [24, 25]. In order to utilize the discrete element 
method (DEM), the nanoparticles are assumed to be sufficiently large (> 500 nm) [26]. As the MNPs are bigger 
than 500nm, the Brownian motion which is more effective in smaller sized particles is excluded from the model 
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where the subscript i indicates particle i, mi is the particle mass, vpi is the particle velocity, FMF is the magnetic 
force, Fdrag is the hydrodynamic drag force, Fm is the gravitational force (gravity and buoyancy), and Fetc includes 
un-modeled forces like electrostatic and adhesive forces, which are neglected due to their small contributions. The 
drag force on the particles is derived using Stokes’ Law as: 
)vv(F fpdrag d −−= 3  (2) 
where vp and vf are the particle and fluid velocities, respectively, d is the particle diameter, and η is the fluid 
viscosity. The gravity and buoyancy force is described as follows: 
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where d is the particle diameter, g is the gravity constant, and ρp and ρb are the densities of the particle and blood, 
respectively. As buoyancy and gravity have opposite directions, the total force exerted on the particles is presented 
in Eq. 3 (Fm). For all cases, the direction of Fm is along the -Z axis (X and Y are shown in Fig. 2 B, and Z is 
defined by the Right-hand Rule). FMF is the steering force that is presented in the next subsection. 
The MNPs are subjected to a magnetic force in the magnetic field, which is used as an actuation force to steer the 
MNPs and is defined as: 
fsatMF MV HF = 1  (4) 
where Msat is the magnetic polarization,  Hf is the functionalized gradient of the magnetic intensity, the 
permeability in the medium is considered to be µ1 = µ0 (µ0 is the permeability of the free space), and the aggregates 
are considered to be rod-shaped and their volume is represented as V. The aggregates have a diameter of d 
(individual particle’s diameter) and height of h. The height of a rod-shaped aggregate is nd, where n is the number 
of nanoparticles in the aggregate. The aggregate has a volume of V=π/4(nd3); therefore, the diameter of an 
equivalent spherical particle for the simulation is described as: 
dndeq
3 3=  (5) 
In the simulation, to illustrate the aggregation effects, the particles are considered to have equivalent diameter deq. 
The functionalized gradient field is defined as: 
H)(H = tSFf  (6) 








































































The ttrS is the starting time of the transport function (TFF), TE is the duration of transport, and α is the asymmetry 
ratio. The SF (Fig. 2 A) is given mainly by the three functions in Eq. (7). The asymmetrical field function (AFF) 
is designed to capture and guide all particles to the first safe zone. The transporter field function (TFF) is designed 
to transport all particles to the next Safe Zone. The sustainer field function (SFF) is designed to keep the particles 
within the safe zone and facilitate movement of the particles with the flow (all three functions are illustrated 
separately in Fig. 2 B). The minus sign means that the actuation is applied in the reverse direction (here it is the 
right coil). 
Once the MNPs aggregate, they are subject to a stronger magnetic force, which causes them to move rapidly 
inside the vessel. To compensate for this high magnetic force and to keep the particles inside the safe zone, a field 
function with an asymmetrical magnitude is proposed (AFF). The asymmetry of the AFF is designed to impose 
more force in the direction of, and capture all particles inside, the safe zone. At the same time, α (the asymmetry 
ratio) is designed to prevent the particles from leaving the safe zone and to move them forward with the blood 
flow until the particles reach the second bifurcation (ttrs1, illustrated in Fig. 3). 
Then, TFF is used to transfer the MNPs to the next safe zone; the TFF activates the EMA in the reverse 
direction and transports all of the particles to the second safe zone. The force is applied during the period TE, 
which is the time needed for all particles to move into the next safe zone (illustrated in Fig. 3).  
The SFF is used to keep the particles within the safe zone without sticking. The same sequence of TFF-SFF 
can be applied to steer the particles through the remaining bifurcations. 
Fig. 3 illustrates the particle path with multi-bifurcation guidance. When there is no magnetic force 
(illustrated in grey), the minimum time for the MNPs to reach the first bifurcation is defined as TL. With EMA 
guidance (illustrated in red), the minimum time needed to steer all of the particles to the safe zone is Tc. 
Incorporating the forces in Eq. 1, the trajectories of the particles can be determined. 
 
2 3 Algorithm for guidance 
The Flowchart in Fig. 4 was used to design and optimize the SF in COMSOL software (COMSOL, Palo Alto, 
CA, USA). Initially, a CAD model and the simulation constants were imported to the software using the 
information in Table 1. The algorithm has three distinct steps for SF design. 
Initially, the minimum required time to guide all particles to the safe zone (Tc) must be determined using the 
simulation software. The time to guide particles to the safe zone is directly linked to the magnitude of the magnetic 
force (Eq. 4) and the magnetic force is a function of the gradient field (H). Therefore, if H is chosen initially, 
the condition TL > Tc should be checked. If the condition is not satisfied, the gradient field should be increased 
gradually until all particles are in the safe zone. The maximum gradient field (H= 2.23 × 106 (A/m2)) is applied 
in the simulation based on the maximum gradient field applicable in our previously used experimental setup [17]. 
Although higher values for the gradient field can be achieved, we limit the parameter (maximum H = 2.3 
MA/m2) to show a possible realistic implementation of the developed simulations.   
The first step is to capture and move all of the MNPs inside the safe zone. The AFF consists of the following 
parameters: the asymmetry ratio α and the frequency with a 2-to-1 duty ratio (illustrated in Fig. 2). The 2-to-1 
duty ratio in the AFF imposes more force towards the safe zone and captures all the particles. The frequency is 
considered sufficiently high to prevent the particles from leaving the safe zone (the simulation considers a constant 
frequency). The asymmetry ratio α is in the range 0 < α ≤ 1 to facilitate movement of the particles inside the safe 
zone, and to prevent the particles from sticking and showing aggregation effects. The simulation determines the 
minimum time required for the particles to reach the second bifurcation (ttrs) when the AFF is applied (see ttrs1 in 
Fig. 3). In real experiments, this time can be measured using the real-time MPI monitoring system introduced in 
[28]. Since the branches used in the simulation have similar geometries, ttrs is initially considered to be 2TL. Upon 
checking the particle trajectory, if the particles have not reached the second bifurcation, the operating time ttrs for 
AFF is increased until the condition is satisfied. 
In the second step, TE (the time required to execute TFF) is considered to be two times Tc to guide all the 
MNPs to the next safe zone, and the magnitude of TFF is considered to be 1.  In the third step, to keep the particles 
inside the second safe zone and move them toward the desired outlet, a SFF of magnitude equal to α is used (a 1-
to-1 duty ratio). This function is used to facilitate particle movements inside the safe zone. The third and fourth 
steps of the algorithm can be repeated for guidance through multiple bifurcations. To study the targeting 
performance, the algorithm was used for different values of asymmetry α and various blood velocities. 
 
3. Results and discussion 
We imported the multi-channel model into COMSOL and used the particle-tracking module to study the 
proposed EMA actuation scheme for multi-channel guidance. 
3. 1 Simulation and results 
A multi-bifurcation vessel (as shown in Fig. 2 B with 45˚ angle from vessel direction for all branches) with 
one inlet and four outlets (all with a diameter of 1 mm) and a length of 5 mm (for all branches) was modelled. A 
steady state blood flow (with 1:1 distribution in the bifurcations) was simulated inside the channels and the 
velocity profile for the multi-bifurcation vessel was calculated using the computational fluid dynamics CFD 
module of COMSOL. The drag force was also considered in the simulation. The 3D model was generated and 
automatically meshed. 
Experimental studies in [15] indicate that the majority of MNPs in a magnetic field form rod-shaped 
aggregates. To match the simulation with the experimental data, the average aggregate was considered to be 100 
µm high (the simulation constants are presented in Table 1). The particles were assumed to be spherical MNPs 
with a diameter of deq and density of 2.25 g/cm3.  The particle simulation motions based on the EMA actuation 
match the guidance time Tc for the Safe Zone reported in experimental studies [15] (illustrated in Fig. 4A). 
Three bifurcations were used in this simulation and 1,000 particles were released at the inlet; however, the 
same approach can be extended to more bifurcations. The simulation results in Fig. 5B, show that the particles are 
steered magnetically using SF(t) to reach the targeted outlet. 
Table 2 summarizes the simulation results for the time needed to reach the first bifurcation. These indicate 
that MNPs reach the bifurcation very quickly with a high blood velocity and the proposed design loses its 
feasibility. The trend is shown in Fig. 5C. Fig. 5C-3 illustrates that for Vf = 10 mm/s, some particles exit the safe 
zone and 100% guidance is not achievable. 
The time needed for all the particles to enter the safe zone depends on the gradient field (H). Fig. 5A 
shows that Tc in this simulation is in agreement with the results published in [17]. Fig. 5D shows that the higher 
gradient field quickly captures the particles in the simulation and makes particle steering more feasible. 
 
3. 2 Discussion 
The number of MNPs reaching the desired outlet is calculated by the software and is considered as an indicator 
of success. Fig. 6 presents the targeting results for different magnitudes of α and different blood velocities. The 
blood velocity is varied between 0.5 and 100 mm/s (the blood velocity in capillaries varies between 0.5 and 1 
mm/s [29]) and the asymmetry ratio α is varied between 0.16 and 1. Also, it shows that in the absence of a magnetic 
force, only a small portion of the particles (first column in Fig. 6 for all velocity conditions) reaches the desired 
outlet, which is located in the far branch of the multi-bifurcation network (Fig. 5B). This indicates that for lower 
velocities, the targeting performance could reach 100%. Although 100% targeting cannot be achieved for a 
velocity equal to 10 mm/s, a maximum 98.5% targeting performance can be achieved. Fig. 6 indicates that the 
targeting performance varies slightly when α is varied between 0.16 and 1. It also shows that with a high blood 
velocity, the targeting performance is reduced. This occurs because TL is very small and all particles cannot enter 
the safe zone (the first condition TL > Tc is not satisfied); and there are always some particles in the incorrect outlet 
(illustrated in Fig. 5C-1). Despite this decrease in targeting performance, for velocities as high as 25 mm/s, a 
targeting rate of 57% can be achieved, which indicates an acceptable performance even at a high blood velocity. 
The limitation of the scheme is also shown in Fig. 6, where under very high flow velocity (100 mm/s) conditions, 
the guidance strategy loses performance and becomes ineffective. In conclusion, Fig. 6 indicates that the success 
in MNPs steering depends on flow velocity. For velocities up to 5 mm/s, 100% of MNPs exit the first branch and 
can be guided to the desired outlet. However, if the low flow velocity cannot be achieved, the success rate of 
MNPs steering will decrease. 
The strategy for swarm nanoparticles steering under fluid flow is discussed and simulated in the current study. 
The results have encouraged us to perform further experimental studies in the future. The proposed scheme has 
two possible applications: 1) it can be used for in vitro lab on chip applications to deliver cargoes using MNPs or 
swarm of microrobots in a complex multi bifurcation environment, 2) it can be used as a magnetic navigation 
system for in vivo drug delivery using our recently developed MPI which has a millimetre scale, fast response 
(<0.5 s frame update rate), and 60 mm × 60 mm region of interest [15, 30-32]. Although the region of interest is 
too small for human scale application, it can be used for in vivo animal tests. The region of 60 mm × 60 mm is 
chosen based on previously developed experimental set-up for MPI-based magnetic nanoparticle monitoring and 
steering [32]. MPI has already been tested in vivo on small animals [33] and in the most recent works, its potential 
to be scaled up for applications in the human brain was explored [34].  
Despite the immediate potential for in vitro applications, further system developments of MPI in terms of region 
of interest, image quality, and simultaneous monitoring and actuation functions are required for use in clinical 
applications. Furthermore, for in vivo clinical experiments, it is necessary to control the blood flow using 
techniques like temporary embolization [23]. On the other hand, the scheme presented here can be used with pre-
clinical systems such as X-ray and MRI based navigation [14, 35]. To sum up, the proposed scheme can be 
successfully used in the future for in vivo and in vitro applications.  
 
4 Conclusion 
The recently developed MPI system has made feasible the implementation of a steering scheme in multi-
bifurcation blood vessels. This paper proposes an electromagnetic-based steering scheme for guiding swarms of 
MNPs inside a multi-bifurcation network. The proposed magnetic steering scheme can successfully guide 
nanoparticles between the safe zones and steer them toward the desired outlet. With low blood velocities, a 
targeting performance of 100% is achieved. With higher blood velocities, the targeting performance is reduced. 
However, even for a blood velocity of 25 mm/s, a targeting performance of 57% is achieved, which shows that 
the proposed scheme has a high targeting performance for a broad range of blood velocities. Future work should 
include a user in the loop control strategy, as most targeted drug delivery systems are semi-automatic and a human 
controls the MDT to ensure safety. 
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ρp Particle density 2.25 g/cm3 
d Particle diameter 800 nm 
ρb Blood density 1.05 g/cm3 
η Blood viscosity 0.004 Pa.s 
T Blood temperature 293.15 K 
L Average aggregate length 100 μm 
n Average number of particles 125 
TE Time for guiding MNPs to Safe Zone TE = 2Tc 
deq Equivalent diameter 5.6 μm 
 H Gradient field 2.23 (MA/m2) 
Msat Magnetic polarization 58 (emu/g) 
FrAFF Frequency of AFF 1.23 Hz 


















The time needed by MNPs to reach the first bifurcation (TL) for different flow velocities. 
Symbol  
TL 2.61 s 0.52 s 0.26 s 



















Steering Function SF (t) 
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Fig. 2 A) The asymmetrical field function (AFF), transporter field function (TFF), and sustainer field function 
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Fig. 5. A) Comparing the experimental results [9] with the simulation. B) Particle tracking under the designed 
SF(t) (the particle path from inlet to outlet is illusturated) can guide the particles to the desired outlet (Vf = 0.5 
mm/s and  H = 2.3 MA/m2). C) Particle tracking simulation to show the effects of different velocities. D) 
Particle tracking simulation to show the effects of different magnetic fields (Vf = 0.5 mm/s, simulaton time Ts = 
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